Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

January 21, 2021

Use of automated quantitative pupillometric evaluation for monitoring the severity of diabetic retinopathy.

Arquivos brasileiros de oftalmologia
Veysel CankurtaranEren Gurkan
January 23, 2021
Open Access

CKD and CKDu in northern Peru: a cross-sectional analysis under the DEGREE protocol.

BMC Nephrology
Andrea Ruiz-AlejosAntonio Bernabé-Ortiz
January 21, 2021
Open Access

Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes.

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Tri Juli Edi TariganMelva Louisa
January 22, 2021

Urinary liver-type fatty-acid binding protein is a predictor of mortality in individuals with type 2 diabetes.

Diabetic Medicine : a Journal of the British Diabetic Association
Hidetaka Hamasaki
January 23, 2021

The role of adipose tissue M1/M2 macrophages in type 2 diabetes mellitus.

Diabetology International
Shiho Fujisaka
January 21, 2021

Effectiveness of a locality-based integrated diabetes care service on clinical outcomes.

Internal Medicine Journal
Reetu ZaroraDavid Simmons
January 24, 2021

Upsurge in autophagy, associated with mifepristone-treated polycystic ovarian condition, is reversed upon thymoquinone treatment.

The Journal of Steroid Biochemistry and Molecular Biology
Paramita SahaRakesh K Tyagi
January 24, 2021

Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy.

Pall KarlssonAndreas C Themistocleous
January 24, 2021

The effects of saxagliptin on cardiac structure and function using cardiac MRI (SCARF).

Acta Diabetologica
Paul SandhuKim A Connelly
January 23, 2021
Open Access

Long Non-Coding RNAs (lncRNAs) in Cardiovascular Disease Complication of Type 2 Diabetes.

Nurruzanna IsmailSiti Aishah Sulaiman
January 21, 2021

Change in HbA1c and Quality of Life with Real-time CGM Use by People with Insulin-Treated Diabetes in the Landmark Study.

Diabetes Technology & Therapeutics
Timothy GilbertWilliam Polonsky

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2021 Meta ULC. All rights reserved